Skip to Main Content

Paper Details

Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab.
Neurol Neuroimmunol Neuroinflamm
14
2020
Author NameAffiliation
Axel PetzoldAmsterdam University Medical Centers, Vrije Universiteit Amsterdam, Vrije Universiteit Amsterdam Department of Ophthalmology (A.P.), Hanover Medical School, UCL Institute of Neurology, University College London and National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (F.B.)
  • 1 - 1

Datasets